Finding gene biomarkers could help diagnosis of rare and lethal cancer

In a collaboration between Arizona State University, the Biodesign Institute, and Phoenix Children's Hospital, three researchers hope to understand more about desmoplastic small round cell tumor (DSRCT). The aim is to find biomarkers and targets to help diagnose and treat this cancer, which mostly affects boys and young adults. Less than a fifth of patients will survive for more than 5 years after diagnosis. Hyundai Hope on Wheels is funding the project with $250,000 over three years, and the researchers will start with next-generation sequencing of tumor samples, followed by bioinformatic analysis. Press release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.